Menu
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Overview
This workshop will be conducted in Japanese Language only.
Online Registration has been closed. Onsite Registration will be available at Nihonbashi Life Science Building.
Program Committee
-
Asami Ezaki, MS • Division of Strategic Planning and Evaluation & Office of Drug Discovery Support
Japan Agency for Medical Research and Development, Japan -
Yasuhiro Honsho • Associate Director, Safety & Risk Management Department
Daiichi Sankyo Co., Ltd., Japan -
Yuji Ito • Prescribing Information Group, RA Functions Dept., Regulatory Affairs Japan
Novartis Pharma K.K., Japan -
Kana Maruyama • Manager, Labeling Group, Regulatory Maintenance Department, RA Division
Janssen Pharmaceutical K.K., Japan -
Ken Nakajima, RPh • Quality Assurance Division Safety Management Department
Otsuka Pharmaceutical Factory, Inc, Japan -
Yuji Ohne • Pharmacutical Officer, PMS management supervisor, Head of Pharmacovigilance Dept
SymBio Pharmaceuticals Limited, Japan -
Keinosuke Okazaki • Office of pharmacovigilance ll
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Mikiko Shitara • Senior Manager, Regulatory Affairs Dept.
Alexionpharma GK, Japan -
Rie Matsui, RPh • Senior Director, Regional Labeling Head for APAC
Japan -
Akiyoshi Uchiyama • President
Artage Inc., Japan
